The Cure Sickle Cell Initiative: Catalyzing Progress via Innovative Interfaces Between NIH, Patients, Academics, ASH, and the Private Sector
Dr. Edward Benz provides some background on the discovery of sickle cell disease and development of the Cure Sickle Cell Initiative. Dr. Ify Osunkwo adds further perspectiv
A New Standard of Care for Children and Young Adults With T-cell Acute Lymphoblastic Leukemia
Dr. Teachey reviews a study that shows outstanding outcomes for children and young adults with T-cell acute lymphoblastic leukemia that have raised the bar and established
Dr. Moss looks at a study that focuses on the activity of prophylactic emicizumab in patients with hemophilia who do not have inhibitors.
Dr. Moss reviews a study that looks at selective forces that drive the migration of the hematopoietic niche into bone.
Dr. Moss reviews a study that demonstrates the success of using gene therapy for the genetic correction of thalassemia.
Dr. Moss discusses the CLARITY study, which looks at the combination of therapies venetoclax and ibrutinib to treat relapsed/refractory chronic lymphocytic leukemia.
Dr. Moss reviews the pathogenesis and potential eradication of favism.
Dr. Moss covers several trials that have solidified the use of venetoclax as the new backbone within a range of combination therapies that should achieve extremely deep therapeutic responses in CLL.
Dr. Moss evaluates a case that requires CAR-T cell therapy and discusses practical issues hematologists should be aware of during introduction of this treatment.
Dr. Moss covers a radical revision of the classification of dendritic cells and monocytes.
Dr. Moss reviews the first trial to show that an immunotherapeutic agent improves survival over chemotherapy in relapsed or refractory ALL patients.
Dr. Moss reviews the first phase III randomized study in systemic mastocytosis (SM), focusing attention on the unmet need of patients with indolent forms of SM who have refractory mediator symptoms despite the use of conventional medications.
November-December 2018Volume 15, Issue 6
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology